Toxic epidermal necrolysis induced by sintilimab in a patient with advanced non-small cell lung cancer and comorbid pulmonary tuberculosis: A case report

Immune checkpoint inhibitors (ICIs) have had a revolutionary effect on the treatment of patients with advanced non-small cell lung cancer (NSCLC), especially squamous cell lung cancer. However, ICIs may cause associated immune-related adverse events (ir-AEs). No case of sintilimab-induced toxic epid...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Gang, Gong, Sheng, Wang, Ning, Yao, Xiaojun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459224/
https://www.ncbi.nlm.nih.gov/pubmed/36090976
http://dx.doi.org/10.3389/fimmu.2022.989966

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9459224/
https://www.ncbi.nlm.nih.gov/pubmed/36090976
http://dx.doi.org/10.3389/fimmu.2022.989966

Ejemplares similares